{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:15:34Z","timestamp":1766553334518,"version":"3.48.0"},"reference-count":27,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union-NextGenerationEU","award":["BG-RRP-2.004-0009-C02"],"award-info":[{"award-number":["BG-RRP-2.004-0009-C02"]}]},{"DOI":"10.13039\/501100006379","name":"Medical University\u2014Varna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006379","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reports"],"abstract":"<jats:p>Background and Clinical Significance: Urothelial carcinoma is one of the most commonly diagnosed malignant diseases. However, it has a much more favorable prognosis than other significantly less common malignancies. This statement, however, is true only for conventional urothelial carcinomas, not for those with divergent differentiation or a special type of urothelial carcinoma. Case Presentation: Herein, we present a case report of an 80-year-old female patient with multiple predominantly cardiovascular comorbidities and vascular dementia, who presented to our institution with genital bleeding. Clinical and diagnostic tests were difficult due to patient noncooperation; however, abdominal computer tomography and cystoscopy showed an advanced tumor originating from the ventral bladder wall. Histology of the tumor showed an invasive urothelial malignancy with foci of clear-cell (glycogen-rich) variant and dispersed, pleomorphic cells, which were immunohistochemically positive for beta-human chorionic gonadotropin. Hence, the diagnosis of high-grade urothelial carcinoma with clear-cell (glycogen-rich) morphology and divergent trophoblastic differentiation was established. Patient outcome was poor. Conclusions: While conventionally having a somewhat favorable prognosis, special subtypes and divergent differentiation in urothelial carcinomas, which warrant a high-grade diagnosis are not only rare but also highly aggressive conditions. Further challenges arise in their differential diagnosis with other advanced malignancies, which can develop in adjacent organs in both genders<\/jats:p>","DOI":"10.3390\/reports9010003","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T11:43:31Z","timestamp":1766403811000},"page":"3","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-Grade Urothelial Carcinoma with Clear-Cell (Glycogen-Rich) Features and Divergent Trophoblastic Differentiation: A Histopathological Case Report"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6950-0615","authenticated-orcid":false,"given":"George","family":"Stoyanov","sequence":"first","affiliation":[{"name":"Department of Pathology, Multiprofile Hospital for Active Treatment, 9700 Shumen, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dobri","family":"Marchev","sequence":"additional","affiliation":[{"name":"Department of Urology, Multiprofile Hospital for Active Treatment, 9700 Shumen, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Pavlov","sequence":"additional","affiliation":[{"name":"Department\u00a0of Pathology, Complex Oncology Center, 9700 Shumen, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ghenev","sequence":"additional","affiliation":[{"name":"Department of General and Clinical Pathology, Forensic Medicine and Deontology, Faculty of Medicine, Medical University\u2014Varna, 9002 Varna, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hristo","family":"Popov","sequence":"additional","affiliation":[{"name":"Department of General and Clinical Pathology, Forensic Medicine and Deontology, Faculty of Medicine, Medical University\u2014Varna, 9002 Varna, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Satyal, U., Srivastava, A., and Abbosh, P.H. (2019). Urine Biopsy\u2014Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01266"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/jama.2017.0364","article-title":"Cystoscopy","volume":"317","author":"Matulewicz","year":"2017","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cncr.28397","article-title":"Trends in Stage-Specific Incidence Rates for Urothelial Carcinoma of the Bladder in the United States: 1988 to 2006","volume":"120","author":"Nielsen","year":"2014","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2005.03.009","article-title":"Upper Urinary Tract Cancer: Location Is Correlated with Prognosis","volume":"48","author":"Antonini","year":"2005","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Soualhi, A., Rammant, E., George, G., Russell, B., Enting, D., Nair, R., Van Hemelrijck, M., and Bosco, C. (2021). The Incidence and Prevalence of Upper Tract Urothelial Carcinoma: A Systematic Review. BMC Urol., 21.","DOI":"10.1186\/s12894-021-00876-7"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.urology.2024.06.035","article-title":"Does Ta Low-Grade Urothelial Carcinoma of the Bladder With Focal High-Grade Features Carry Worse Prognosis? The Roswell Park Comprehensive Cancer Center Experience","volume":"193","author":"Mahmood","year":"2024","journal-title":"Urology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clgc.2020.07.011","article-title":"Bladder Cancer: A Comparison Between Non-Urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities","volume":"19","author":"Deuker","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/bju.12468","article-title":"Stage, Grade and Pathological Characteristics of Bladder Cancer in the UK: British Association of Urological Surgeons (BAUS) Urological Tumour Registry","volume":"113","author":"Boustead","year":"2014","journal-title":"BJU Int."},{"key":"ref_10","first-page":"e72603","article-title":"Urothelial Carcinoma With Divergent Glandular Differentiation","volume":"16","author":"Popov","year":"2024","journal-title":"Cureus"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/1752-1947-8-275","article-title":"Clear Cell Urothelial Carcinoma of the Urinary Bladder: A Case Report and Review of the Literature","volume":"8","author":"Knez","year":"2014","journal-title":"J. Med. Case Rep."},{"key":"ref_12","first-page":"79","article-title":"Transitional Cell Carcinoma Exhibiting Clear Cell Features. A Differential Diagnosis for Clear Cell Adenocarcinoma of the Urinary Tract","volume":"119","author":"Kotliar","year":"1995","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/1066896916660195","article-title":"Clear Cell Urothelial Carcinoma","volume":"25","author":"Mai","year":"2017","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.humpath.2014.02.024","article-title":"Immunohistochemical Evaluation of Novel and Traditional Markers Associated with Urothelial Differentiation in a Spectrum of Variants of Urothelial Carcinoma of the Urinary Bladder","volume":"45","author":"Paner","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0046-8177(98)90015-6","article-title":"Clear Cell Adenocarcinoma and Nephrogenic Adenoma of the Urethra and Urinary Bladder: A Histopathologic and Immunohistochemical Comparison","volume":"29","author":"Gilcrease","year":"1998","journal-title":"Hum. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/PAS.0000000000001589","article-title":"Clear Cell Adenocarcinoma in Men: A Series of 15 Cases","volume":"45","author":"Grosser","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.humpath.2009.10.011","article-title":"Clear Cell Adenocarcinoma of the Bladder and Urethra: Cases Diffusely Mimicking Nephrogenic Adenoma","volume":"41","author":"Herawi","year":"2010","journal-title":"Hum. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.humpath.2009.02.016","article-title":"Pleomorphic Giant Cell Carcinoma of the Urinary Bladder","volume":"40","author":"Blanca","year":"2009","journal-title":"Hum. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/PAT.0b013e3283560172","article-title":"Recently Described and Unusual Variants of Urothelial Carcinoma of the Urinary Bladder","volume":"44","author":"Samaratunga","year":"2012","journal-title":"Pathology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/his.12785","article-title":"Pleomorphic Giant Cell Carcinoma of the Urinary Bladder: An Extreme Form of Tumour de-Differentiation","volume":"68","author":"Samaratunga","year":"2016","journal-title":"Histopathology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/PAS.0000000000001532","article-title":"Urothelial Carcinomas With Trophoblastic Differentiation, Including Choriocarcinoma: Clinicopathologic Series of 16 Cases","volume":"44","author":"Przybycin","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.humpath.2003.09.012","article-title":"Mixed Micropapillary and Trophoblastic Carcinoma of Bladder: Report of a First Case with New Immunohistochemical Evidence of Urothelial Origin","volume":"35","author":"Regalado","year":"2004","journal-title":"Hum. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/1097-0142(19930301)71:5<1835::AID-CNCR2820710519>3.0.CO;2-5","article-title":"Transitional Cell Carcinoma of the Renal Pelvis with Chriocarcinomatous Differentiation. Immunohistochemical and Immunoelectron Microscopic Assessment of Human Chorionic Gonadotropin Production by Transitional Cell Carcinoma of the Urinary Bladder","volume":"71","author":"Grammatico","year":"1993","journal-title":"Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-5347(17)44882-8","article-title":"Carcinoembryonic Antigen and Beta-Human Chorionic Gonadotropin as Serum Markers for Advanced Urothelial Malignancies","volume":"136","author":"Dexeus","year":"1986","journal-title":"J. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/bjc.2014.89","article-title":"Serum Total HCG\u03b2 Level Is an Independent Prognostic Factor in Transitional Cell Carcinoma of the Urothelial Tract","volume":"110","author":"Douglas","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.mce.2006.02.019","article-title":"Ectopic HCGbeta Expression by Epithelial Cancer: Malignant Behaviour, Metastasis and Inhibition of Tumor Cell Apoptosis","volume":"260\u2013262","author":"Iles","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_27","first-page":"7658657","article-title":"Unusual Type of Acinar Adenocarcinoma of the Prostate With Low PSA: A Histopathological Report of Two Cases of Pleomorphic Giant Cell Adenocarcinoma","volume":"2025","author":"Stoyanov","year":"2025","journal-title":"Case Rep. Oncol. Med."}],"container-title":["Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/1\/3\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:10:58Z","timestamp":1766553058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/1\/3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["reports9010003"],"URL":"https:\/\/doi.org\/10.3390\/reports9010003","relation":{},"ISSN":["2571-841X"],"issn-type":[{"type":"electronic","value":"2571-841X"}],"subject":[],"published":{"date-parts":[[2025,12,22]]}}}